- Global Pharma News & Resources

Antifungal Drug Market Share 2019 – Revenue Forecasts and Regional Analysis till 2028

The “Global Antifungal Drug Market 2019” report is a demanding study of the market represent the state-of-the-art details in the market. It also forecast its growth in the next few years. The Antifungal Drug report access several aspects that discover the growth as well as the volume of the Global Antifungal Drug Market.

Fungal infections are caused by microscopic organisms that can invade in the epithelial tissue. The fungal kingdom includes yeasts, molds, rusts and mushrooms. Fungi, like animals, are hetrotrophic, that is, they obtain nutrients from the environment. Most fungi are beneficial and are involved in biodegradation process. However, a few can cause fungal infections, if they are introduced into the skin through wounds, or into the lungs and nasal passages if inhaled etc. Diseases caused by fungi include superficial infections of the skin by dermatophytes in the microsporum, trichophyton or epidermophyton genera. Antifungals drugs mostly target specific components of fungal plasma membrane or its biosynthetic pathway for treatment.

Request for Sample Report @

Segmentation by drug type: Echinocandins, Caspofungin, Micafungin, Anidulafungin, Others, Azoles, Imidazoles, Voricanazole, Thiazoles, Others (Including econazole etc.), Polyenes, Amphotericin B, Candicidin, Hamycin, Natamycin, Others (including Filipin, Hamycin etc.), Allylamines, Butenafine, Terbinafine, Naftifine, Others (including terbinafine, amorolfin etc.), Others (Including tolnaftate, griseofulvin etc.). Segmentation by route of administration: Oral, Parenteral, Topical. Segmentation by route of therapeutic indication: Aspergillosis, Dermatophytosis, Candidiasis, Others (including blastomycosis, mucormycosis etc.) – Global Forecast to 2028

It Also Includes a Number of Top Key Players:

Pfizer Inc.
Sanofi S.A
Gilead Sciences and Inc.
GlaxoSmithKline Plc. and Inc.
Novartis International AG
Abbott Laboratories
Bayer AG
Scynexis Inc.
Enzon Pharmaceuticals and Inc.
Merck & Co.

The Global Antifungal Drug Market is Segmented on the Basis of Regions:

01. North America ( United States)

02. Europe ( Germany, France, UK)

03. Asia-Pacific ( China, Japan, India)

04. Latin America ( Brazil)

05. Middle East & Africa

Key Highlights from Antifungal Drug Market Study:

01. Revenue and Sales Analysis — Historical Revenue and sales size is presented and further data is triangulated with top-down and bottom-up come near to forecast fulfilled market size and to evaluate forecast numbers for key regions covered in the report along with confidential and well identified types and end-use industry. Additionally macroeconomic factor and regulatory policies are ascertained in Antifungal Drug industry evolution and predictive analysis.

02.Manufacturing Analysis — This report is currently inspect regarding various product type and application. The Antifungal Drug Market give a chapter spotlighting manufacturing process analysis approve by primary data collected by Industry experts and Key officials of profiled companies.

03. Competition — Leading players have been studied depending on their company profile, product case, volume, product/service price, sales & profit.

04. Demand & Supply and Effectiveness — Antifungal Drug report also provides distribution, Production, Consumption & EXIM** (Export & Import). ** If applicable.

Have Any Query? Ask Our Experts @

In the end, the report avails market players with such game-changing recommendations which helps them to improve their business accordingly and maximize their profits. It also provides profitable business plans and making informed decisions for the future.

Contact Us At:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876


Email ID:

Editor Details

Last Updated: 31-Jul-2019